CHA2DS2-VASc score predicts 30-day readmission due to thromboembolic complications following cardioversion of atrial fibrillation: insights from US National Readmissions Database.
Benjamin BuckToshimasa OkabeAvirup GuhaEmile DaoudPublished in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2019)
This study demonstrated the utility of CHA2DS2-VASc score in predicting TEC-associated readmission rate following CV and the temporal relationship of TEC to CV. Patients > 65 years old without other comorbidities may benefit from 30-day OAC following successful CV irrespective of the duration of AF episodes.
Keyphrases
- atrial fibrillation
- left atrial
- catheter ablation
- oral anticoagulants
- end stage renal disease
- direct oral anticoagulants
- left atrial appendage
- heart failure
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- quality improvement
- emergency department
- venous thromboembolism